Somagenetix
Zurich, CH · 11 employees on LinkedIn · 2 known investors
Find your way into Somagenetix
Somagenetix is a gene therapy company that develops treatments for genetic diseases, particularly phagocyte-driven immune and neurodegenerative disorders, by correcting DNA at its source. Founded as a spin-out of the University of Zurich, the company aims to deliver one-time curative treatments for previously incurable genetic conditions.
Investors · 2
.jpeg){kind=logo}
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AOct 2024Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Somagenetix do?
- Somagenetix is a gene therapy company that develops treatments for genetic diseases, particularly phagocyte-driven immune and neurodegenerative disorders, by correcting DNA at its source. Founded as a spin-out of the University of Zurich, the company aims to deliver one-time curative treatments for previously incurable genetic conditions.
- Who are Somagenetix's investors?
- Somagenetix's investors include Verve Ventures, VI Partners.
- Where is Somagenetix headquartered?
- Somagenetix is headquartered in Zurich, CH.